Clinical Trial

SPN-817 Open-Label Extension Study in Adults With Focal Onset Seizures

Name: SPN-817 Open-Label Extension Study in Adults With Focal Onset Seizures — clinical trial record (NCT07141329)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a Phase 2b open-label extension study to evaluate the long-term safety and efficacy of SPN-817.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-08-19.

Trial Details

NCT Number	NCT07141329
Lead Sponsor	Supernus Pharmaceuticals, Inc.
Conditions	Focal Onset Seizures
Enrollment	100 participants
Start Date	2025-07-30
Primary Completion	2027-12-31 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-10-10